Montgomery County - County Board of Education - School Operation Requirements MC 14-26
Summary
HB1084 revises Maryland law governing medication-assisted treatment for incarcerated individuals in local correctional facilities. The bill removes the existing requirement that each local jail make available at least one formulation of each FDA-approved opioid medication category used to treat opioid use disorder, and instead focuses on ensuring that facilities assess incarcerated individuals for mental health and substance use needs, provide evaluation by qualified practitioners, offer appropriate medication-assisted treatment, continue treatment during incarceration or transfer when medically appropriate, and create prerelease reentry plans that address continuity of care, peer support, and insurance enrollment.
The bill also shifts the funding structure for these services. It requires the Secretary of Health, through the Office of Overdose Response, to provide each county an annual grant equal to the county’s documented costs for implementing the medication-assisted treatment program, subject to reporting requirements and possible reductions for late reporting. The Governor is authorized to include an appropriation in the annual budget bill for these grants, and the Opioid Restitution Fund is expanded to allow grants to counties for this purpose. The bill amends reporting requirements so the state receives more detailed data on treatment use, costs, and prerelease planning in local correctional facilities.
Impact
HB1084 would amend the Correctional Services Article to make medication-assisted treatment requirements for local correctional facilities more explicitly tied to assessment, clinical evaluation, treatment continuity, counseling, peer recovery support, and reentry planning, while deleting the prior mandate that facilities stock at least one formulation of each FDA-approved opioid treatment medication category. It would also amend the State Finance and Procurement Article to authorize use of the Opioid Restitution Fund for county grants supporting jail-based medication-assisted treatment programs, and to require annual county reporting and state grant calculations based on documented implementation costs. Counties, local detention centers, the Maryland Department of Health, the Office of Overdose Response, and the Governor’s budget process would all be directly affected.
Sentiment
The bill appears generally supportive of expanding and stabilizing access to opioid use disorder treatment for incarcerated people, with an emphasis on continuity of care and state reimbursement for county costs. The text suggests a policy approach aimed at standardizing treatment and reducing financial barriers for local facilities. No committee transcript or vote record was provided, so there is no recorded floor or committee sentiment beyond the bill’s stated purpose and structure.
Contention
The main policy shift is financial and operational: counties would be reimbursed for implementation costs, but they would also have to report detailed utilization and cost data, and grants could be reduced for late reporting. Another possible point of contention is the removal of the explicit requirement that each local facility stock at least one formulation of each FDA-approved opioid medication category, which may be viewed either as reducing a rigid mandate or as narrowing guaranteed medication access. The bill also relies on Opioid Restitution Fund dollars and budget appropriations, so funding availability and the use of settlement money for jail-based treatment may be debated by fiscal and public health stakeholders.